Scientific programme

Scientific programme

This Congress will showcase a plethora of relevant topics in the exciting field of Transfusion Medicine, from recruitment of blood donors to the actual donation process, biology of blood cells, preparation of blood components, transfusion-transmitted infectious diseases, immunohaematology patient blood management, adverse transfusion events, cellular therapies, and much more. There will be workshops on writing a scientific paper, peer reviewing and epidemiology. Special sessions will be organized for transfusion practitioners. We will once again hold a Young Investigators breakfast session.

The local day will focus on topics that are relevant to the Eastern Mediterranean region and the highly educational Academy day gives you the opportunity to refresh your knowledge and/or hear a summaries of interesting research findings from vein to vein. The main scientific programme will include the ISBT Presidential Award and the Jean Julliard Prize plenary sessions.

Click Here to Access the Congress Abstract Book

The congress abstract book is now available through the Wiley Online Library. You can freely access it online by clicking above, or access it via the congress app in due time. 

EACCME

The 'International Society of Blood Transfusion' (or) '34th International Congress of the ISBT' is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net 

The '34th International Congress of the ISBT' is designated for a maximum of (or 'for up to') 33 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme 

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.


EACCME credits
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event.

PROGRAMME PER DAY **

08.20 - 08.30Welcome
08.30 - 09.30Donors and donation
08.30 - 09.00STATUS OF BLOOD SAFETY AND AVAILABILITY IN THE WHO EASTERN MEDITERRANEAN REGION
Yetmgeta E. Abdella
09.00 - 09.30STRATEGIES TO IMPROVE THE DONOR RECRUITMENT PROCESS
Rana Al Abdulrazak
09.30 - 10.00Coffee Break

 

 

10.00 - 12.00Clinical aspects
10.00 - 10.30APPROPRIATENESS OF TRANSFUSION SERVICE (PATIENT APPROPRIATENESS)
Irene Sadek
10.30 - 11.00PLATELET REFRACTORINESS - CAUSE AND MANAGEMENT
Joseph Sweeney
11.00 - 11.30MASSIVE TRANSFUSION PROTOCOLS: HOW TO STANDARDIZE PRACTICE
Manuel Algora
11.30 - 12.00TRANSFUSION IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS
Mohamed Al Mohamedi
12.00 - 13.30Lunch Break

 

 

13.30 -15.00Quality management/Haemovigilance/TTI
13.30 -14.00BLOOD SUPPLY EMERGENCY & DISASTER PLANNING
May Raouf
14.00 - 14.30IMPLEMENTATION OF NATIONAL HAEMOVIGILANCE PROGRAMME
Salwa Hindawi
14.30 -15.00THE ENBTC (EGYPTIAN NATIONAL BLOOD TRANSFUSION CENTRE’S) JOURNEY TO AABB ACCREDITATION :STEPS AND CHALLENGES
Afaf Ahmed Ali
15.00 - 15.30IS IT TIME TO START HEPATITIS E TESTING - DONOR CENTRE PERSPECTIVE
Gheyath K Nasrallah
15.30-16.00Coffee Break

 

 

16.00 -17.30Blood/blood components and products
16.00-16.30AUTOMATION IN BLOOD PROCESSING
Magdy Al Aqiabi
16.30-17.00COMPARISON OF WHOLE BLOOD AND APHERESIS PLATELETS
Joseph Sweeney
17.00-17.30PLASMA FRACTIONATION MOROCAAN EXPERIENCE
Khadija Lahjouji

 

 

09.00 - 10.30Practical approach and spectrum of donors and donation
09.00 - 09.30EFFECTIVELY RECRUITING AND RETRAINING REGULAR VOLUNTARY BLOOD DONORS 
Al AbdulRazzak (Kuwait)
09.30 - 10.00OVERCOMING BLOOD SUPPLY CHALLENGES IN MULTI-ETHNIC DONOR AND PATIENT POPULATIONS
Wooi Seong (Malaysia)
10.00 - 10.30UNDERSTANDING IRON DEPLETION AND OVERLOAD
Sheila O’Brien (Canada)
09.00 - 10.30Practical approach in immunohaematology and the spectrum of immunohaematology
09.00 - 09.30RED CELL ALLOANTIBODIES - CLINICAL SIGNIFICANCE OR NOISE
Jenny White (UK)
09.30 - 10.00INTRODUCING GENOTYPING INTO ROUTINE PRACTICE
Jill Storry (Sweden)
10.00 - 10.30SOLVING DIFFICULT CASES IN AUTOIMMUNE HAEMOLYTIC ANAEMIA
Lilian Castilho (Brazil)
10.30 - 11.00Coffee Break

 

 

11.00 - 12.30Practical approach and spectrum of organisation and quality
11.00 - 11.30MANAGING HAEMOVIGILANCE PROGRAMMES AT HOSPITAL AND NATIONAL LEVEL
Salwa Hindawi (Saudi Arabia)
11.30 - 12.00ASSESSING CLINICAL BLOOD DEMAND - HOW MUCH DO WE REALLY NEED
Mart Janssen (Netherlands)
12.00 - 12.30AIMING FOR QUALITY AND ACCREDITATION IN THE HOSPITAL BLOOD BANK
Peter Flanagan (New Zealand)
11.00 - 12.30Practical approach to transfusion therapy and the spectrum of transfusion therapy
11.00 - 11.30MANAGING THE PATIENT WITH HAEMOGLOBINOPATHY AND MULTIPLE RED CELL ANTIBODIES
A Matteocci (Italy)
11.30 - 12.00UNDERSTANDING THROMBOTIC THROMBOCYTOPENIC PURPURA
Marie Ann Scully (UK)
12.00 - 12.30ALLOANTIGENS ON NEUTROPHILS AND PLATELETS IN MULTI-ETHNIC POPULATIONS
Sentot Santoso (Germany)
12.30 - 13.30Lunch Break

 

 

13.30 - 15.00Practical approach and spectrum of TTID
13.30 - 14.00THE LATEST IN HEPATITIS B AND C
Masahiro Satake (Japan)
14.00 - 14.30GLOBAL CHALLENGES OF MANAGING MALARIA RISK
Alex Owusu Ofori (Ghana)
14.30 - 15.00Approaching the assessment of novel pathogens
Roger Dodd (USA)
13.30 - 15.00Practical approach in clinical transfusion and the spectrum of clinical transfusion
13.30 - 14.00MANAGING BLEEDING EMERGENCIES
Shubha Allard (UK)
14.00 - 14.30MANAGING THE CHRONICALLY TRANSFUSED PATIENT
Vip Viprakasit (Thailand)
14.30 - 15.00MANAGING NON-INFECTIOUS ADVERSE TRANSFUSION REACTIONS
Gwen Clarke (Canada)
15.00 - 15.30Coffee Break

 

 

15.30 - 17.00Practical approach and spectrum of blood components and supply management
15.30 - 16.00AUTOMATION IN BLOOD PROCESSING - IS IT COST EFFECTIVE
Magdy El Ekiaby (Egypt)
16.00 - 16.30APPROACHES TO ASSESSING AND MINIMISING BLOOD WASTAGE IN THE HOSPITAL AND BLOOD SUPPLY CHAIN
Nicola Yates (UK)
16.30 - 17.00THE MEASUREMENT OF BLOOD COMPONENT QUALITY
Dana Devine (Canada)
15.30 - 17.00Practical approach to cell therapy and the spectrum of cell therapy
15.30 - 16.00SUPPORTING BLOOD NEEDS IN PATIENTS UNDERGOING HEMATOPOIETIC CELL TRANSPLANTATION
John Miller (USA)
16.00 - 16.30HLA TYPING IN DIVERSE POPULATIONS
Rhonda Holdsworth (Australia)
16.30 - 17.00NEW CELLULAR THERAPIES FROM BLOOD COMPONENTS
Mickey Koh (London)
17.30 - 18.15Opening Ceremony
Sheikh Rashid E
18.15 - 21.00Opening of the Trade Exhibition and Welcome Reception



07.00 - 08.15Young Investigators Breakfast 
08.30 - 10.00Workshop Peer Review
08.30 - 10.00Transfusion Medicine I
09.30 - 10.00

ELEARNING TO IMPROVE PATIENT BLOOD MANAGEMENT AND CLINICAL TRANSFUSION PRACTICE: DOES IT MAKE A DIFFERENCE?  

D. M. Peterson (Australia)

08.30 - 09.30Selected abstracts
08.30 - 09.00Donor recruitment
08.30 - 09.00

HOW CAN WE ENCOURAGE OUR VOLUNTARY NON-REMUNERATED DONORS TO DONATE MORE FREQUENTLY?

Tanya Davison (Australia)

09.00 - 10.00Selected abstracts
08.30 - 10.00Cellular Therapies WP Session
08.30 - 09.00

HOW CAN BLOOD BANKS EVOLVE INTO CELL THERAPY UNITS

Christian Gabriel (Austria)
09.00 - 09.30

HEMATOPOIETIC STEM CELLS AND ITS USE IN REGENERATIVE MEDICINE

Reinhard Henschler (Switzerland)
09.30 - 10.00

TRANSPLANTATION AND CELLULAR THERAPY IN THE MIDDLE EAST

S.O. Ali Ahmed (Saudi Arabia)
08.30 - 10.00Blood Group Immunogenetics and Terminology WP Session
08.30 - 09.00

A NOVEL DATABASE FOR BLOOD GROUP ALLELES

Martin L. Olsson (Sweden)
09.00 - 09.30

FULL LENGTH NUCLEOTIDE SEQUENCE OF ERMAP ALLELES ENCODING SCIANNA (SC) ANTIGENS

Willy Flegel (To Be Confirmed)
09.30 - 10.00

COMPREHENSIVE RED BLOOD CELL AND PLATELET ANTIGEN PREDICTION FROM WHOLE GENOME SEQUENCING

Connie Westhoff (USA)
08.30 - 10.00Blood Processing
08.30 - 10.00

MINI POOL PLASMA FRACTIONATION; AN ALTERNATIVE ACCESS TO SAFE PLASMA PRODUCTS

Magdy El Ekiaby (Egypt)
08.30 - 10.00Selected abstracts
10.00 - 10.30Coffee break



10.30 - 12.00New insights in mechanisms and consequences of haemolysis
10.30 - 11.00

MECHANISMS OF HEME TOXICITY IN HEMOLYSIS AND PROTECTION BY THE HEME-BINDING PROTEIN, HEMOPEXIN
Ann Smith (USA)

11.00 - 11.30ANIMAL MODELS OF HAEMOLYSIS
Magnus Gram (Sweden) 
11.30 - 12.00COMPLICATIONS FOLLOWING RED BLOOD CELLS TRANSFUSION - CLINICAL HYPERHAEMOLYSIS
Susan Robinson (UK)
12.00 - 14.00Lunch Break

 

 

14.00 - 15.30Apheresis and Haemovigilace
14.00 - 15.30 Selected abstracts
14.00 -15.30Young Investigators Scientific Session
14.00 - 15.30Selected abstracts
14.00 - 15.30Donor health
14.00 -14.30HEALTH EFFECTS OF BLOOD DONATION AND IRON DEPLETION
Henrik Ullum (Denmark)
14.30 - 15.30Selected abstracts
14.00 - 15.30Malaria
14.00 - 14.30 PREVENTION OF TRANSFUSION TRANSMITTED MALARIA
Shirley 
Owusu (Ghana)
14.30 - 15.30Selected abstracts
14.00 - 15.30Platelets and HLA
14.00 - 14.30ACID STRIPPING CREATES FULLY FUNCTIONAL HLA-DEFICIENT
PLATELETS THAT ESCAPE IMMUNE DESTRUCTION BY HLA ANTIBODIES
Petter Hoglund (Sweden)
14.30 - 15.00DENGUE VIRUS REPLICATION IN PLATELETS
Ed Pryzdial (Canada)
15.00 - 15.30Selected abstracts
15.30 - 16.00Coffee Break

 

 

16.00 - 17.30Global Blood Safety WP session
16.00 - 16.30

THE ROLE OF GLOBAL BLOOD SAFETY IN THE ZIKA AGE

Silvano Wendel (Brazil)

16.30 . 17.00

THE FRENCH DRY PLASMA (FLYP) EXPERIENCE IN MILITARY AND CIVILIAN USE

Anne Sailliol (France)

17.00 - 17.30

IS THERE ANY ROLE FOR PATHOGEN REDUCTION METHODS ON A GLOBAL SCALE?

Jean-Pierre Allain (UK)

16.00 - 17.30Risk models
16.00 - 16.30RISK BASED DECISION MAKING FOR BLOOD SAFETY
Dana Devine (Canada)
16.30 - 17.30Selected abstracts
16.00 - 17.30Sequencing technologies
16.00 - 16.30NEXT GENERATION SEQUENCING FOR BLOOD GROUP GENOTYPING
Yann Fichou (France)
16.30 - 17.30Selected abstracts
16.00 - 17.30Exciting Developments in Platelets
16.00 - 16.30PLATELETS FOR REGENERATIVE MEDICINE – WHAT ABOUT EVIDENCE?
Katharina Schallmoser (Austria)
16.30 - 17.00CURRENT METHODS TO MANUFACTURE HUMAN PLATELET LYSATES,
AND POSSIBLE TRENDS IN PRODUCT SAFETY AND STANDARDISATION
Thierry Burnouf (France)
17.00 - 17.30

3D SILK BONE MARROW MODEL FOR PLATELET PRODUCTION

Alessandra Balduini, Christian A. Di Buduo, Alessandro Pecci, Carlo L. Balduini, David L. Kaplan (Italy)

16.00 - 17.30Thrombosis and Haemostasis
16.00 - 16.30ENGINEERED RBCS AS CARRIERS FOR SYSTEMIC DELIVERY
Nai-Jia Huang (USA)
16.30 - 17.00ROLE OF RED CELLS IN THROMBOSIS AND HAEMOSTASIS
John Weisel (USA)
17.00 - 17.30Selected abstracts

 

 

08.30 - 09.30Jean Julliard Prize session
08.30 - 09.00INTRODUCTORY PRESENTATION
09.00 - 09.25BIG DATA IN TRANSFUSION MEDICINE – TOWARDS A DATABASE DRIVEN APPROACH 
TO ENSURING THE LONG-TERM HEALTH OF 
BOTH BLOOD DONORS AND TRANSFUSED PATIENTS AS THE BEST SUBMISSION
Gustaf Edgren (Sweden)
09.25 - 09.30Prize Ceremony
09.30 - 10.00Coffee Break
10.00 - 11.30Presidential Award session

 

 

14.00 - 15.30Blood safety - emerging infectious diseases
14.00 - 14.30VIRAL SHEDDING AND ANTIBODY RESPONSE IN MERS
Ziad Memish (Saudi Arabia)
14.30 - 15.30Selected abstracts
14.00 - 15.30Blood Supply Management WP Session
14.00 - 14.30

THE AUSTRALIAN BLOOD AND BLOOD PRODUCT WASTAGE REDUCTION PROGRAMME

Greg Wilkie (Australia)

14.30 - 15.00

BLOOD SUPPLY MANAGEMENT IN THE USA - CURRENT TRENDS 

Merlyn Sayers (USA) 

15.00 - 15.30

STATEWIDE COLLABORATION FOR BLOOD INVENTORY MANAGEMENT  

Rick Tocchetti (Australia)

14.00 - 15.30Workshop Writing a scientific paper
14.00 - 15.30Plasma donation
14.00 - 14.30DONOR MANAGEMENT
Mahtab Maghsoodlu (Iran)
14.30 - 15.30Selected abstracts
14.00 - 15.30Clinical Transfusion WP Session
14.00 -14.10

WHERE DOES BLOOD GO? - A UK SURVEY

Shubha Allard (UK)

14.10 - 14.35

TRANSFUSION IN THE ELDERLY PATIENT  

Zoe McQuilten (Australia)

14.35 - 15.10

RED BLOOD CELL TRANSFUSION STRATEGIES IN HAEMATO-ONCOLOGY

Marlijn Hoeks (The Netherlands)

15.10 - 15.30

PBM STUDIES IN OBSTETRICS

Charlotte Holm (Denmark)

14.00 - 15.30Implications of Red Cell Alloimmunisation
14.00 - 14.30EVIDENCE AGAINST A ROLE FOR RED CELL CLEARANCE IN 
ANTIBODY-MEDIATED PREVENTION OF ERYTHROCYTE ALLOIMMUNIZATION
Alan Lazarus (Canada)
14.30 - 15.30Selected abstracts
15.30 - 16.00Coffee Break

 

 

16.00 - 17.30Classical TTI
16.00 - 17.30Selected abstracts
16.00-17.30Blood group genotyping
16.00 - 16.30COST EFFECTIVENESS OF IMPLEMENTING MOLECULAR IMMUNOHAEMATOLOGY
Greg Denomme (USA)
16.30 - 17.30Selected abstracts
16.00 - 17.30Red Cell Storage
16.00 - 16.30RED CELL STORAGE LESION
Angelo D’Alessandro (USA)
16.30 - 17.30Selected abstracts
16.00 - 17.30Transfusion Medicine II
16.00 - 16.30TRANSFUSION AND TREATMENT OF SEVERE ANAEMIA IN AFRICAN CHILDREN: A RANDOMISED CONTROLLED TRIAL 
Kathryn Maitland (Kenya)
16.30 - 17.00MANAGEMENT OF THALASSAEMIA
Vip Viprakasit (Thailand)
17.00 - 17.30Selected abstracts
16.00 - 17.30Platelets Immunology
16.00 - 16.30PLATELET IMMUNOBIOLOGY WP WORKSHOP RESULTS
Sentot Santoso (Germany)
16.30 - 17.30Selected abstracts
17.30 - 18.30Poster Session (Exhibition Area)

 

 

08.30 - 10.00Blood Group Antigen
08.30 - 10.00Selected abstracts
08.30 - 10.00Quality Management WP Session
08.30 - 09.00

ERROR MANAGEMENT IN TRANSFUSION MEDICINE

Tomislav Vuk (Croatia)

09.00 - 10.00Selected abstracts
08.30 - 10.00Cryopreservation of Platelets
08.30 - 09.00IN VITRO EVALUATION OF THE HAEMOSTATIC CAPACITY OF CRYOPRESERVED 
PLATELETS AND PLATELET SUBSTITUTES
Miguel Lozano (Spain)
09.00 - 10.00Selected abstracts
08.30 - 10.00Haemovigilance WP Session
08.30 - 10.00Selected abstracts
08.30 - 10.00TTID WP session
08.30 - 10.00Selected abstracts
10.00 - 10.30 Coffee Break

 

 

10.30 - 12.00Emerging Arboviruses and Transfusion
10.30 - 12.00THE GLOBAL EPIDEMIOLOGY OF ARBOVIRUSES WITH FOCUS ON ZIKA`
Lyle Petersen (USA)
10.30 - 12.00EPIDEMIOLOGY, VIROLOGY, AND MOLECULAR ASPECTS OF THE ARBOVIRUSES EPIDEMICS IN BRAZIL
Jose Eduardo Levi (Brazil)
10.30 - 12.00ZIKA VIRUS (ZIKV) TRANSFUSION TRANSMISSION AND ITS PREVENTION: THE US EXPERIENCE
Jay Epstein (USA)
12.00 - 14.00Lunch Break

 

 

14.00 - 15.30Donors and Donation WP Session 
14.00 - 15.30Selected abstracts
14.00 - 15.30Management and Organisation 
14.00 - 15.30Selected abstracts
14.00 - 15.30Transfusion Technologies 
14.00 - 15.30Selected abstracts
14.00 - 15.30Sickle cell disease
14.00 - 14.30DEVELOPING NEW PHARMACOTHERAPEUTIC APPROACHES TO TREATING SICKLE CELL DISEASE
Marilyn J. Telen (USA)
14.30 - 15.00TRANSFUSION SUPPORT IN SICKLE CELL DISEASE
Connie Westhoff (USA)
15.00 - 15.30IMMUNE REGULATION OF SICKLE CELL ALLOIMMUNIZATION
Karina Yazdanbakhsh (USA)
14.00 - 15.30Red cell antibodies
14.00 - 14.30COMPLEX RED CELL ANTIBODY CASE ANALYSIS
Nicole Thornton (UK)
14.30 - 15.30Selected abstracts
14.00 - 15.30TP Session: Managing blood use appropriately
15.30 - 16.00 Coffee Break

 

 

16.00 - 17.30Arbo viruses 
16.00 - 16.30ZIKA VIRUS AND BLOOD TRANSFUSION EXPERIENCES FROM FRENCH POLYNESIA
Didier Musso (French Polynesia)
16.30 - 17.00Selected abstracts
16.00 - 17.30Rare Donors WP Session
16.00 -17.30Selected abstracts
16.00 - 17.30Information Technology WP Session
16.00 - 16.50

WILL THE INTERNET OF THINGS (IOT) DRIVE TRANSFORMATION CHANGE IN HEALTHCARE?

R. Davis (USA)

16.50 - 17.30Updates on Task Forces
16.00 - 17.30Impact of drugs on transfusion
16.00 - 16.30EXTENDING THE REACH OF THERAPEUTIC AGENTS TO TRANSFUSION
Pablo Bartolucci (France)
16.30 - 17.30Selected abstracts
16.00 - 17.30 TRALI mechanisms
16.00 - 16.30NON-ANTIBODY MEDIATED TRALI - CURRENT UNDERSTANDING
Alexander Vlaar (Netherlands)
16.30 - 17.00INTERACTION OF NEUTROPHIL ANTIBODIES WITH ENDOTHELIAL CELLS IN TRALI
Behnaz Bayat (Germany)
17.00 - 17.30Selected abstracts
19.30 - 23.30
Congress Party

 

 

08.30 - 10.00Immunohaematology WP Session
08.30 - 10.00Bacterial detection
08.30 - 09.00RBC ADHESION MOLECULES AND VESICULATION ARE ESSENTIAL
FOR EFFICIENT IMMUNE ADHERENCE CLEARANCE

Robin van Bruggen (The Netherlands)
09.00 - 10.00Selected abstracts
08.30 - 10.00Post partum and other major haemorrhage
08.30 - 09.00THE INDONESIAN APPROACH TO PREVENT MATERNAL MORTALITY
Yuyun Soedarmono (Indonesia)
09.00 - 09.30STATE OF THE ART ON OBSTETRIC TRANSFUSION PRACTICE, THE REDS PROGRAM
Evan Bloch (USA)
09.30 - 10.00Selected abstracts
08.30 - 10.00Immunohaematology WP session
08.30 - 09.00

SEROLOGIC VS. MOLECULAR TESTING

Thierry Peyrard (France)

09.00 - 10.00Case Studies
10.00 - 10.30 Coffee Break

 

 

10.30 - 12.00Future direction of Transfusion Medicine
10.30 - 12.00CULTURED RBCs FOR TRANSFUSION, HOW FAR ARE WE?
Emile van den Akker (Netherlands)
10.30 - 12.00ETHICAL ASPECTS OF MEDICAL PRODUCTS OF HUMAN ORIGIN
Dominique Martin (Australia)
10.30 - 12.00PATIENT BLOOD MANAGEMENT – IMPROVES RED BLOOD CELL USAGE AND PATIENT SAFETY
Kai Zacharowski (Germany)
12.00 - 12.30Closing Ceremony
12:30 - 13.30Farewell Lunch

 

 

APPLICATIONS ARE CLOSED

ISBT will offer a workshop (Tuesday September 6, 14.00-15.30 hrs) on writing scientific papers for people who are new or relatively new (3 papers or less) to scientific writing and who wish to learn or improve their writing skills. It will consist of an introductory lecture followed by one on one discussion of your draft scientific paper.

 

 

ISBT is looking for early career scientists who are willing to be reviewers for papers in Vox Sanguinis, the ISBT Science Series and submitted congress abstracts. Therefore, we will host a workshop (Monday September 5, 8.30-10.00 hrs in Abu Dhabi B) on peer review during the congress.

Peer review is the method by which grants are allocated, papers published and much more. Yet there is very little training in peer review, often it is up to the new reviewer to find their own way around the joys and difficulties of the review process.

Becoming involved in peer review can be very informative, help you with your own scientific writing and be a career enhancing experience. It is an opportunity to get yourself on the map and a good addition to your c.v.

The workshop is open to early career scientists who wish to offer themselves as peer reviewers and to find out how to navigate around the process. It is also open to current reviewers who wish to refresh their reviews or find out more about peer review within ISBT.

The application deadline for this workshop has passed.

The application deadline for this workshop has passed.

After our earlier courses in Seoul and London, this year also we will organize a one-day introductory course on the most important aspects of designing, performing, analyzing, reporting and reading clinical transfusion research. If you want to know what study design is best to answer your question, which control group(s) to choose, what your study size should be and when and how to control for confounding, this course will not only help you with your own studies but also with interpreting literature on these topics.

The workshop will be held on Sunday, September 4, 9.00 - 17.00 in Dubai E.

When signing up for this course we would like to know your current experience with (clinical) research and what aspects of clinical research you would like to know more about. The number of participants for this course is limited.

 

 

The workshop will consist of presentations, group work and exercises and the workshop is organised and facilitated by the ISBT Working Party on Quality Management.

The application deadline for this workshop has already passed.

The workshop will take place on September 4, 2016 13.30 – 17.00.

The application deadline for this workshop has passed.

The workshop will consist of presentations, discussion and live demonstrations. Click here to access the programme. Following the workshop participants will be able to understand the definition of a clinically significant antibody, gain insight into the tools available to predict the clinical significance of alloantibodies, gain an understanding of the current information available about blood group alloantibodies and be aware of the Notify library international database and understand how to participate. Participants will be encouraged to share practical experiences. The workshop is organised and facilitated by the ISBT Working Party on Immunohaematology. The workshop will take place on Friday, September 2 in Fujairah A.

Monday September 5, 2016

7.00-8.15 hrs
Sheikh Rashid Tower (DWTC)

A breakfast is organized to informally bring YI together with Transfusion Medicine experts. The breakfast is held at the 31st floor of the Sheikh Rashid Tower (DWTC).

The application deadline for the breakfast has passed. 

 

 

Transfusion practitioners (TP) whether known as transfusion nurses, transfusion safety officers, haemovigilance officers or patient blood management (PBM) practitioners play an integral role in the blood management team. In many countries they are the driving influence in clinical blood management activities, including PBM initiatives.

During the congress there will be targeted sessions promoting the TP role. Topics will include patient safety initiatives, strategies to enhance the appropriate use of blood components, and a workshop on how to make data work for you. View the complete programme below.

A networking afternoon tea to meet and exchange ideas across organisations and countries has been included after the success of a similar networking session in London. An online TP Forum will also be launched at this congress to support ongoing networking.

The TP forum has been established for TPs and those who are interested in the role from around the world to get together to learn and share strategies, successes and even the barriers in this emerging area.

I along with all the members of the steering committee look forward to meeting you at the congress.
We hope that you will be able to join us.

Linley Bielby
Chair-Transfusion Practitioner Forum

 

Monday, September 5           16.00 - 17.30             Patient Safety
16.00 - 16.10INTRODUCING THE TRANSFUSION PRACTITIONERS FORUM
Shubha Allard (UK) and Linley Bielby (Australia)
16.10 - 16.35THE TRANSFUSION PRACTITIONER ROLE USING HAEMOVIGILANCE TO IMPROVE PATIENT SAFETY
Rozemarijn Deelen (Netherlands)
16.35 - 17.00HOW THE TRANSFUSION PRACTITIONER ROLE CAN INVOLVE PATIENTS IN THE TRANSFUSION PROCESS
Rachel Moss (UK)
17.00 - 17.25THE USE OF TECHNOLOGY IN PATIENT SAFETY
Aman Dhesi (UK)
17.25 - 17.30
Questions?
Tuesday, September 616.00-17.30
Best use of data to change practice
16.00-17.30WORKSHOP* – ‘MAKING DATA FUN AND WORK FOR YOU’
Rozemarijn Deelen (Netherlands), Rachel Moss (UK), Aman Dhesi (UK), Linley Bielby (Australia) and Jens Svanholt Seeberg (Denmark)
Wednesday, September 7           14.00-15.30Managing blood use appropriately
14.00-14.30SINGLE UNIT TRANSFUSIONS (HOW TO MEASURE PRACTICE – WHAT HAS WORKED)
Jens Svanholt Seeberg (Denmark)
14.30-15.00DIFFERENT STRATEGIES USED TO IMPLEMENT PREOPERATIVE ANAEMIA ASSESSMENT
Linley Bielby (Australia)
15.00-15.30BLOOD USE IN MAJOR HAEMORRHAGE
Shubna Allard (UK)
15.30- 16.30Transfusion Practitioner forum networking afternoon tea
Linley Bielby (Australia). Rachel Moss (UK), Aman Dhesi (UK), Jens Svanholt Seeberg (Denmark) and Rozemarijn Deelen (Netherlands)

 

* The workshop 'Making data fun and work for  you' will involve delegates working through a series of 'how to stations' facilitated by Transfusion Practitioners.

08.30 - 10.00WP Blood Group Immunogenetics and Terminology
08.30 - 08.50A NOVEL DATABASE FOR BLOOD GROUP ALLELES
TBA
08.50 -09.10FULL LENGTH NUCLEOTIDE SEQUENCE OF ERMAP ALLELES ENCODING SCIANNA (SC) ANTIGENS
Willy Flegel
09.10- 09.30 COMPREHENSIVE RED BLOOD CELL AND PLATELET ANTIGEN PREDICTION
FROM WHOLE GENOME SEQUENCING
Connie Westhoff
09.30 - 09.45Oral abstract
09.45 - 10.00Oral abstract

 

 

08.30 - 10.00WP Cellular Therapies
08.30 - 09.00HOW CAN BLOOD BANKS EVOLVE INTO CELL THERAPY UNITS
Christian Gabriel (Austria)
09.00 -09.30HAEMATOPOIETIC STEM CELLS AND ITS USE IN REGENERATIVE MEDICINE
Reinhard Henschler (Germany)
09.30- 10.00TRANSPLANTATION AND CELLULAR THERAPY IN THE MIDDLE EAST
Syed Osman Ali Ahmed (Saudi Arabia)

 

 

16.00 - 17.30WP Global Blood Safety
16.00 - 16.30THE ROLE OF GLOBAL BLOOD SAFETY IN THE ZIKA AGE
Silvano Wendel (Brazil)
16.30 - 17.00THE FRENCH DRY PLASMA (FLYP) EXPERIENCE IN MILITARY AND CIVILIAN USE
Anne Sailliol (France)
17.00 - 17.30IS THERE ANY ROLE FOR PATHOGEN REDUCTION METHODS ON A GLOBAL SCALE?
Jean Pierre Allain (UK)

 

 

14.00 - 16.30WP Blood Supply Management
14.00 - 14.30THE AUSTRALIAN BLOOD AND BLOOD PRODUCT WASTAGE REDUCTION PROGRAMME
Jacqui Caulfield (Australia)
14.30 - 15.00BLOOD SUPPLY MANAGEMENT IN THE USA - CURRENT TRENDS
Merlyn Sayers (USA)
15.00 - 15.30TOWARDS GOOD PRACTICES IN BLOOD SUPPLY MANAGEMENT
Gilles Follea (France)

 

 

14:00 - 15:30 WP Clinical Transfusion
14:00 - 14:10WHERE DOES BLOOD GO? - A UK SURVEY
Shubha Allard (UK)
14:10 - 14:35TRANSFUSION IN THE ELDERLY PATIENT
Zoe McQuilten (Australia)
14:35 - 15:10RED BLOOD CELL TRANSFUSION STRATEGIES IN HAEMATO-ONCOLOGY
Marlijn Hoeks (Netherlands)
15:10 - 15:30PBM STUDIES IN OBSTETRICS
Charlotte Holm (Denmark)

 

 

08.30 - 10.00WP Quality Management
08.30 - 09.00ERROR MANAGEMENT IN TRANSFUSION MEDICINE
Tomislav Vuk (Croatia)
09.00 - 09.20COST OF GOOD VERSUS POOR QUALITY – CONFORMANCE VERSUS NON-CONFORMANCE
Lesley Bust (South Africa)
09.20 - 09.40QUALITY AND SAFETY REGARDING RECOVERED AND SOURCE PLASMA OF VNRBDSs
Paul Strengers (Netherlands)
09.40 - 10.00SUBSTANCES OF HUMAN ORIGIN – PROCESS MANAGEMENT AND RISK ASSESSMENT
Christian Seidl (Germany)

 

 

08.30 - 10.00WP TTID
08.30 - 09.00SUBGROUP ON SURVEILLANCE, RISK ASSESSMENT AND POLICY
Sheila O'Brien (Canada)
09.00 - 09.20SUBGROUP ON PARASITES
David Leiby (USA)
09.20 - 09.40SUBGROUP ON BACTERIA
Carl McDonald (UK)
09.40 - 10.00TTID RESEARCH YOUNG INVESTIGATOR TRAINING (I TRY IT)
Brian Custer (USA)

 

 

08.30 - 10.00WP Haemovigilance
08.30 - 08.55SETTING UP A REGIONAL HEMOVIGILANCE NETWORK AND PROGRESS WITH IMPLEMENTATION
Salwa Hindawi (Saudi Arabia)
08.55 - 09.20NEW HARMONISED DEFINITIONS FOR COMPLICATIONS OF BLOOD DONATION: INTERNATIONAL VALIDATION
Kevin Land (USA)
09.20 - 09.45ASSESSING TACO REPORTS IN HAEMOVIGILANCE AND LESSONS TO BE LEARNED
Harriet Lucero (UK)
09.45 - 10.00Discussion time with all speakers

 

 

14.00 - 15.30WP Donors and Donation
14.00 - 14.25ARGUMENTS AGAINST IRON SUPPLEMENTATION
Wim de Kort (Netherlands)
14.25 - 14.50ARGUMENTS FOR IRON SUPPLEMENTATION
Joseph Kiss (USA)
14.50 - 15.00Discussions and questions
15.00 - 15.30ISSUES IN DONOR INCENTIVES
Christina Zambricki (USA)

 

 

16.00 - 17.30WP Rare Donors
16.00 - 16.10WHEN RARE BLOOD IS NOT AVAILABLE: INTRODUCTION
Christine Francis Lomas (USA)
16.10 - 16.25THE IRANIAN EXPERIENCE: SUPPORTING PATIENTS WHO HAVE RBC
ANTIBODIES WHEN SUITABLE BLOOD IS LIMITED
Mostafa Moghaddam (Iran) 
16.25 - 16.40OPTIONS TO SCREEN FOR RARE DONORS
Hein Hustinx (Switzerland)
16.40 - 17.00THE FRENCH EXPERIENCE: TRANSFUSION SUPPORT FOR PATIENTS WITH
ANTIBODIES TO HIGH PREVALENCE ANTIGENS
Thierry Peyrard (France)
17.00 - 17.15WHEN RARE BLOOD IS AVAILABLE: CHALLENGES OF BRINGING IT TO THE PATIENT
Nicole Thornton (UK) 
17.15 - 17.30RARE DONORS: FINDING ,RECRUITING AND RETENTION
Sandra Nance (USA)

 

 

16.00 - 17.30WP IT
16.00 - 16.50WILL THE INTERNET OF THINGS (IOT) DRIVE TRANSFORMATION CHANGE IN HEALTHCARE?
Rodeina Davis (USA)
16.50 - 17.30Update on Task Forces
16.50 - 17.00INTERFACE
Linda Lodge (UK)
17.00 - 17.10UPDATE ON THE VALIDATION TASK FORCE
Jan-Willem Andriessen (Netherlands)
17.10 - 17.20TRACEABILITY
Paul Ashford (UK)
17.20 - 17.30RFID
Lynne Briggs (USA)

 

 

08.30 - 10.00WP Immunohaematology
08.30 - 09.00SEROLOGIC VS. MOLECULAR TESTING
Thierry Peyrard (France)
09.00 - 09.15CASE STUDY: FALSE POSITIVE PHENOTYPE/TRUE NEGATIVE GENOTYPE
Sofia Lejon Crottet (Switzerland)
09.15 - 09.30CASE STUDY: FALSE NEGATIVE PHENOTYPE/TRUE POSITIVE GENOTYPE
Cinzia Paccapelo (Italy)
09.30 - 09.45CASE STUDY: TRUE NEGATIVE PHENOTYPE/FALSE POSITIVE GENOTYPE
Vanja Karamatic Crew (UK)
09.45 - 10.00CASE STUDY: TRUE POSITIVE PHENOTYPE/FALSE NEGATIVE GENOTYPE
Jill Storry (Sweden)

 

 

DateFrom ToRoomWorking Party members only
Saturday September 3
Transfusion Transmitted Infectious Diseases3-9-20169:0017:00Dubai DNo
WP IT3-9-20168:3017:00Dubai AYes
Rare Donors3-9-20168.30 11.30Dubai Cpre register: CFrancis@remove-this.NYBloodCenter.org 
Red Cell Immunogenetics3-9-201611.4514.45Dubai CYes
Immunohaematology3-9-201615.0018.00Dubai Cpre register: tpeyrard@remove-this.ints.fr
Donors & Donation3-9-20169:0016:00Dubai BNo
Clinical Transfusion3-9-201616:0018:00Dubai BYes
Quality Management3-9-20169:0011:30Dubai EYes
Haemovigilance3-9-201611:3017:00Dubai ENo
Sunday September 4
Global Blood Safety4-9-20169:0012:00Dubai BNo
Standing Committee on Ethics4-9-201610:0013:00Dubai AYes
Blood Supply Management4-9-201614:0016:00Dubai ANo
Apheresis4-9-201610:0012:00Dubai CNo
Cellular Therapies4-9-201612:0013:30Dubai CNo
Monday September 5
ISAC Meeting5-9-201612.00 14.00Dubai CYes
Standing Committee of the ISBT Academy5-9-201615.3017.00Dubai CYes
Wednesday September 7
Standing Committee on Ethics7-9-201614.0016.00Sharjah DYes

** Each parallel session will comprise (an) invited speaker(s) and selected abstracts for oral presentation.

JOIN ISBT TOGETHER WE INCREASE OUR IMPACT ON TRANSFUSION MEDICINE

Quote
Quote

“Sharing the ideas with a group of like-minded friends from all over the world always lights the inspiration and pushes you forward. To join us and enjoy it!”

Ji Yanli, China
Become a member from 55,- euro p/y join us now